Bizarre Patents
A coffin, for allowing inclination for display of a deceased person in a natural position.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8071102 | Methods to clear meningitis causing agents using antibodies to peptides representing epitopic sites for bacterial and viral meningitis causing agents Novel vaccines include polypeptides that comprise regions corresponding to a chemokine and a hapten. The hapten can be an amino acid sequence corresponding to the Meningitis Related Homologous Antigenic Sequences (MRHAS) of bacterial and viral agents known to cause ... | 12/06/2011 |
| 7235644 | Vaccine against Gram-negative bacterial infections A vaccine, effective in inducing the production of antibodies with which to immunize a second subject passively against infection by Gram-negative bacteria and LPS-mediated pathology, comprises a non-covalent polyvalent complex formed between purified, detoxified LP... | 06/26/2007 |
| 7195763 | Surface proteins from gram-positive bacteria having highly conserved motifs and antibodies that recognize them Isolated peptide sequences and proteins containing these sequences are provided which are useful in the prevention and treatment of infection caused by Gram-positive bacteria. The peptide sequences have been shown to be highly conserved motifs in the surface protein... | 03/27/2007 |
| 7025963 | Vaccine against Gram-negative bacterial infections A vaccine, effective in inducing the production of antibodies with which to immunize a second subject passively against infection by Gram-negative bacteria and LPS-mediated pathology, comprises a non-covalent polyvalent complex formed between purified, detoxified LP... | 04/11/2006 |
| 6994854 | Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections The subject of the invention is amino acid sequences of the AC-Hly from B. pertussis, B. parapertussis and/or B. bronchiseptica, carrying epitopes capable of inducing a protective immune response against infection by Bordetella. The subject of t... | 02/07/2006 |
| 6979550 | Method for diagnosis of, and determination of susceptibility to bovine mastitis The present invention discloses a method for detection and prediction of mastitis. The method comprises the steps of determining the values of mastitis indicators and comparing the values with predetermined standards, wherein deviation from the standards provides a ... | 12/27/2005 |
| 6936247 | Filariid anti-P22U antibodies The present invention relates to isolated parasitic helminth nucleic acid sequences capable of hybridizing, under stringent conditions, to at least a portion of D. immitis nucleic acid sequence p4 and/or to at least a portion of D. immitis nucleic acid... | 08/30/2005 |
| 6887481 | Bacterial-derived molecules and therapeutic and diagnostic uses therefor The present invention relates generally to molecules derived from a Mycobacterium species and recombinant, synthetic, derivative, homologue and analogue forms of said molecules. The molecules of the present invention are useful in diagnostic assays for Myc... | 05/03/2005 |
| 6881410 | Treatment of E. faecium infection The present invention provides bacterial and fungal ABC transporter proteins, immunogenic fragments thereof, neutralising agents specific thereto and binding agents specific thereto for therapeutic and diagnostic use, together with diagnostic test methods, methods o... | 04/19/2005 |
| 6803035 | Anti-diarrheal and method for using the same A food product and method for treating and preventing diarrhea in a subject animal suffering from or susceptible to diarrhea. The method comprises administering an egg product to the subject animal wherein the egg product is obtained from a hyperimmunized avian.... | 10/12/2004 |
| 6790661 | System for detecting bacteria in blood, blood products, and fluids of tissues The invention provides methods for screening for the presence of a clinically relevant amount of bacteria in donor blood or a blood product from a donor mammal, particularly blood or a blood product that will be transferred from the donor mammal to a recipient mamma... | 09/14/2004 |
| 6743430 | Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose Disclosed herein is a multicomponent low dose vaccine comprising a safe and immunogenically effective combination of a protective antigen component or components of clostridial organism, a protective antigen component of a non-clostridial organism and an adjuvant. | 06/01/2004 |
| 6733983 | Method for identifying a mycobacterium species The invention relates to a method for identifying a Mycobacterium species comprising the steps of: a) contacting at least one immuno-cross reactive antigen component of a mycobacterial species with a sample of a body fluid of a human or animal individual;... | 05/11/2004 |
| 6713059 | Antibodies raised against immunogenic conjugates of gram-negative bacterial autoinducer molecules The present invention relates to an immunogenic conjugate comprising a carrier molecule coupled to an autoinducer of a Gram negative bacteria. The immunogenic conjugate, when combined with a pharmaceutically acceptable carrier, forms a suitable vaccine for mammals t... | 03/30/2004 |
| 6623737 | Antibodies to intimin-like proteins of E. coli The invention is related to antibodies, particularly monoclonal antibodies, which recognize particularly epitopes of the intimin protein of enteropathogenic E. coli and enterohemorrhagic E. coli, methods of detecting such E. coli by use of these antibodie... | 09/23/2003 |
| 6582925 | Desaturase antigen of mycobacterium tuberculosis The use of genetic methodology based on the fusion of the proteins with the alcaline phosphatase (Lim et al., 1995) has allowed the isolation of a new exported protein of M. tuberculosis. In the present article, first of all the isolation of a gene encodi... | 06/24/2003 |
| 6544516 | Treatment and diagnosis of infections of gram positive cocci The present invention provides bacterial and fungal ABC transporter proteins, immunogenic fragments thereof, neutralizing agents specific thereto and binding agents specific thereto for therapeutic and diagnostic use, together with diagnostic test methods... | 04/08/2003 |
| 6495334 | Recombinant Sef14 fimbrial protein from Salmonella A truncated SE fimbria antigen useful as an antigen for immunoassay diagnosis of Salmonella enteritidis (SE) infection or evidence of infection.... | 12/17/2002 |
| 6416962 | Method and device for identifying a mycobacterium species responsible for a mycobacterial infection The invention relates to a method for identifying a Mycobacterium species responsible for a mycobacterial infection in human or animal, comprising selecting a suitable mycobacterial species and strain; preparing at least one mycobacterial antigen, respect... | 07/09/2002 |
| 6383763 | Detection of mycobacteria The present invention is directed to methods and compositions for the detection of infection and disease due to members of the genus Mycobacterium. In particular, the present invention is well-suited to the detection and identification of patients with di... | 05/07/2002 |
| 6376203 | Glycoglycerophospholipid, antibody thereagainst, and method for detecting mycoplasma Mouse is immunized with an antigen of a lipid fraction originating from Mycoplasma fermentans. Its spleen cells are fused with mouse myeloma cells to prepare hybridomas. A hybridoma is selected, which produces a monoclonal antibody having reaction specifi... | 04/23/2002 |
| 6365156 | Method for improving the half-life of soluble viral-specific ligands on mucosal membranes This invention relates to methods of increasing the half-life of a viral-specific ligand on a mucosal membrane by modifying the viral-specific ligand to bind the bacteria colonized on the mucosal membrane. The invention also provides a chimeric molecule c... | 04/02/2002 |
| 6350449 | Antibodies to meningococcal polysaccharide conjugate vaccines The invention relates to chemically-modified group B polysaccharides of Neisseria meningitidis. The invention also provides vaccines in which the respective modified polysaccharides are conjugated to a protein carrier, and the like, as well as antibodies ... | 02/26/2002 |
| 6258359 | Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides There is provided an immunogenic composition capable of inducing protective antibodies against Helicobacter infection characterized in that it comprises: i) at least one sub-unit of a urease structural polypeptide from Helicobacter pylori (SEQ ID NO: 22,2... | 07/10/2001 |
| 6096310 | Oral immunotherapy of bacterial overgrowth The object of the present invention is the oral administration of animal immunoglobulins for the treatment of gastrointestinal disorders caused by bacterial and/or yeast overgrowth. Immunoglobulins derived from the blood, plasma or serum of animals, such ... | 08/01/2000 |
| 5817473 | Method and device for identifying a mycobacterium species responsible for a mycobacterial infection A method for identifying a Mycobacterium species responsible for a mycobacterial infection in human or animal, comprising selecting a suitable mycobacterial species and strain; preparing at least one mycobacterial antigen, respectively antigen preparation... | 10/06/1998 |
| 5741489 | Passively administered antibody that enhances feed conversion efficiency A method for increasing feed conversion efficiency in mammals, such as swine, wherein the mammal is fed a diet containing an antibody produced using the enzyme urease as the antigen.... | 04/21/1998 |
| 5718899 | Method and compositions for direct concentrated delivery of passive immunity Compositions containing a high concentration of the full repertoire of immunoglobulins, including IgA, IgM and IgG, are used to combat infections from microorganisms and viruses at a wound, surgical, or burn site, or normal tissue at times of risk of infe... | 02/17/1998 |
| 5716793 | Method for diagnosing a patient for chlamydia A method of detecting chlamydia in a extracellular sample is provided which comprises contacting the sample with an idiotypic antibody to GLXA to form an immunocomplex and detecting the immunocomplex.... | 02/10/1998 |
| 5707627 | Methods and compositions for the direct concentrated delivery of passive immunity Compositions containing a high concentration of the full repertoire of immunoglobulins, including IgA, IgM and IgG, are used to combat infections from microorganisms and viruses at a wound, surgical, or burn site, or normal tissue at times of risk of infe... | 01/13/1998 |
| 5700465 | Bovine serum and bovine IgG as preventives and therapeutives for bovine mastitis Immunoglobulin G-2 (IgG2), e g. bovine IgG2, and its reaction with neutrophils can be used to enhance the neutrophil's functional status in host animal defense against bacterial infections.... | 12/23/1997 |
| 5681565 | Methods and compositions for passive immunotherapy The direct, concentrated local delivery of antibodies, and pooled human immunoglobulins in particular, to tissue surfaces (e.g., wounds, burns, etc.), and biomaterial implant surfaces significantly decreases the rate of infection at those sites and enhanc... | 10/28/1997 |
| 5612031 | Antibodies against streptococcus Antibodies which bind the surface antigen I/II of Streptococcus sobrinus serotype d and cross react with the surface antigen I/II of Streptococcus mutans serotypes c, e, f and g and method to combat dental caries by applying the antibodies which bind the ... | 03/18/1997 |
| 5585098 | Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants A method for lowering somatic cell count in the milk of a lactating ruminant is disclosed. IgY antibodies are first obtained from the egg of a hen which has been actively immunized against one or more mastitis-causing pathogenic organisms by injection wit... | 12/17/1996 |
| 5518721 | Antibodies against Streptococcus Monoclonal antibodies which bind the surface antigen I/II of Streptococcus sobrinus serotype d and cross react with the surface antigen I/II of Streptococcus mutans serotypes c, e, f and g and method for producing the antibody. Compositions comprising the... | 05/21/1996 |
| 5505945 | Method and compositions for the direct concentrated delivery of passive immunity Compositions containing a high concentration of the full repertoire of immunoglobulins, including IgA, IgM and IgG, are used to combat infections from microorganisms and viruses at a wound, surgical, or burn site, or normal tissue times of risk of infecti... | 04/09/1996 |
| 5194255 | Antihypertensive hyperimmune milk, production, composition, and use The invention relates to a method for inducing the production of a milk anti-hypertensive factor in an animal, to a method for the isolation of said factor from the milk of said animal in a substantially pure form, and to the use of said factor to treat h... | 03/16/1993 |
| 5106618 | Method of treating protozoal gastrointestinal disorders by administering hyperimmune milk product The invention comprises treatment of gastrointestinal disorders of parasitic protozoan and bacterial origin in immunocompromised and immunocompetent animals by administration hyperimmune milk products.... | 04/21/1992 |
| 4965068 | Polyvalent hyperimmunoglobulin preparation The present invention involves a polyvalent hyperimmunoglobulin preparation having activity against gram negative and gram positive bacteria. Such a polyvalent hyperimmunoglobulin preparation is prepared from plasma, serum or whole blood from donors. Dono... | 10/23/1990 |
| 4897265 | Method for treating disorders of the vascular and pulmonary systems A method for treating vascular disorders or pulmonary disorders associated with smoking in an animal which comprises: administering to the animal milk collected from a bovid being maintained in a hyperimmune state, in an amount and for a time sufficient t... | 01/30/1990 |
